🇺🇸 FDA

Intelligence · Clinical Pipeline

Approved programs Pipeline Programs

ClinicalTrials.gov programs marked approved or launched in registry data.

Programs
1,839

Quick answer

NovaPharmaNews tracks 1,839 approved programs pharmaceutical pipeline programs from ClinicalTrials.gov. ClinicalTrials.gov programs marked approved or launched in registry data.

Top sponsors

Page 27 of 39

  1. Renin-angiotensin system blockers

    Hospital Authority, Hong Kong

    Diabetes

    approved small molecule active

    1 trial

  2. Repatha 140 mg solution for injection in pre-filled pen

    Pari Pharma GmbH

    acute myocardial infarction

    approved small molecule active

    1 trial

  3. Rescue Intravitreal Aflibercept Injection

    Regeneron UK Limited

    Neovascular Polypoidal Choroidal Vasculopathy

    approved small molecule active

    1 trial

  4. Reslizumab

    Teva Pharma GmbH

    Asthma; Eosinophilic

    approved mab completed

    1 trial

  5. Reslizumab

    Teva Pharma GmbH

    Asthma

    approved small molecule active

    5 trials

  6. Resveratrol

    The First People's Hospital of Lianyungang

    Pancreatitis, Acute

    approved small molecule active

    1 trial

  7. Reveal® XT Insertable Cardiac Monitor

    Rhythm Pharmaceuticals Netherlands B.V.

    Cryptogenic Symptomatic Transient Ischemic Attack

    approved other completed

    1 trial

  8. Revefenacin

    Theravance Biopharma Ireland Umited

    Chronic Obstructive Pulmonary Disease

    approved small molecule completed

    1 trial

  9. Reyanning mixture

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Acute Tonsillitis

    approved small molecule active

    1 trial

  10. Ribociclib

    Novartis Pharmaceuticals

    Metastatic Breast Cancer

    approved small molecule active

    1 trial

  11. Rifaldin 300 mg cápsulas, Rimactán 300 mg cápsulas duras, Cemidón 300 B6, RIFAPENTINE

    The George Institute

    Latent tuberculosis infection in patients with end-stage kidney disease.

    approved small molecule active

    1 trial

  12. Rifaximin

    COLLEGIUM PHARMACEUTICAL, INC

    ACS - Acute Coronary Syndrome

    approved small molecule active

    1 trial

  13. Rifaximin

    United Therapeutics Europe Ltd

    Nonalcoholic Fatty Liver Disease

    approved small molecule terminated

    1 trial

  14. Rifaximin

    United Therapeutics Europe Ltd

    Clostridium Difficile Infection

    approved small molecule completed

    1 trial

  15. Rifaximin

    The First People's Hospital of Lianyungang

    IBS - Irritable Bowel Syndrome

    approved small molecule active

    1 trial

  16. Rifaximin Oral Tablet

    Hospital Authority, Hong Kong

    Irritable Bowel Syndrome With Diarrhea

    approved small molecule completed

    1 trial

  17. Risedronate Sodium 35 MG [Actonel]

    Dong Wang

    Postmenopausal Osteoporosis

    approved small molecule completed

    1 trial

  18. Rituximab

    The First People's Hospital of Lianyungang

    Hemophagocytic Lymphohistiocytosis

    approved small molecule active

    1 trial

  19. Rivaroxaban 2.5 MG Oral Tablet [Xarelto]

    The University of Hong Kong

    Atherosclerosis, Coronary

    approved small molecule completed

    1 trial

  20. Rivaroxaban 2.5 mg

    Second Xiangya Hospital of Central South University

    Acute Coronary Syndrome

    approved small molecule completed

    1 trial

  21. Rivastigmine

    Atrium Therapeutics

    Parkinson's Disease

    approved small molecule terminated

    1 trial

  22. Rivastigmine

    Novartis Pharmaceuticals

    Alzheimer's Disease

    approved small molecule completed

    1 trial

  23. Rivastigmine transdermal patch

    Novartis Pharmaceuticals

    Alzheimer's Disease

    approved small molecule completed

    1 trial

  24. Rocuronium

    ELITE PHARMACEUTICALS INC /NV/

    Muscle Relaxation

    approved small molecule completed

    1 trial

  25. Rocuronium Bromide

    ELITE PHARMACEUTICALS INC /NV/

    Muscle Relaxation

    approved small molecule completed

    1 trial

  26. Roflumilast Cream 0.15%

    Arcutis Biotherapeutics

    ITCH

    approved small molecule active

    1 trial

  27. Roflumilast alternated days

    Lxo Ireland Designated Activity Company

    Chronic Obstructive Pulmonary Disease (COPD)

    approved small molecule completed

    1 trial

  28. Ropivacaine

    The First People's Hospital of Lianyungang

    End Stage Renal Disease (ESRD)

    approved small molecule active

    1 trial

  29. Ropivacaine

    The First People's Hospital of Lianyungang

    Radius Fractures

    approved small molecule completed

    1 trial

  30. Ropivacaine B. Braun 10 mg/ml injektionsvätska, lösning

    The George Institute

    lumbar arthrodesis

    approved small molecule active

    1 trial

  31. Rosuvastatin

    Hospital Authority, Hong Kong

    Systemic Lupus Erythematosus

    approved small molecule active

    1 trial

  32. Rosuvastatin

    The First People's Hospital of Lianyungang

    Hyperlipidemia

    approved small molecule active

    1 trial

  33. Rosuvastatin

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Infarction, Anterior Cerebral Artery

    approved small molecule active

    1 trial

  34. Rosuvastatin (5mg，10mg，20mg)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Carotid Atherosclerosis

    approved small molecule active

    1 trial

  35. Rosuvastatin and Ezetimibe morning or evening administration

    COLLEGIUM PHARMACEUTICAL, INC

    Hypercholesterolemia

    approved small molecule completed

    1 trial

  36. Rucacuzumab plus standard therapy

    The First People's Hospital of Lianyungang

    Acute Ischemic Stroke AIS

    approved small molecule active

    1 trial

  37. Ruxolitinib

    The First People's Hospital of Lianyungang

    Safety and Efficacy

    approved small molecule active

    2 trials

  38. S-1

    The First People's Hospital of Lianyungang

    Pancreatic Cancer

    approved small molecule active

    1 trial

  39. S-ketamine & Ropivacaine

    The First People's Hospital of Lianyungang

    Postoperative Analgesia

    approved small molecule active

    1 trial

  40. SALBUTAMOL

    United Therapeutics Europe Ltd

    CHRONIC OBSTRUCTIVE PULMONARY DISEASE

    approved small molecule completed

    1 trial

  41. SALINE, TRANEXAMIC ACID

    Disc Medicine

    Slipped capital femoral epiphysis (SCFE), Legg-Calvé-Perthes Disease (LCPD), Neuromuscular conditions, Secondary hip dysplasia, Developmental dysplasia of the hip (DDH)

    approved small molecule active

    1 trial

  42. SAR231893

    Regeneron UK Limited

    Asthma

    approved small molecule completed

    1 trial

  43. SARS-CoV-2 Inactivated Vaccine

    Sinovac Research and Development Co.,

    COVID-19

    approved mab active

    2 trials

  44. SCE-B

    Teva Pharma GmbH

    Nocturnal Vasomotor Symptoms

    approved small molecule completed

    1 trial

  45. SEG101

    Novartis Pharmaceuticals

    Sickle cell disease

    approved small molecule active

    1 trial

  46. SELPERCATINIB, SELPERCATINIB

    Eli Lilly Co.

    Non Small Cell Lung Cancer; Medullary Thyroid Cancer; Colon Cancer; Breast Cancer; Pancreatic Cancer; Papillary Thyroid Cancer; Other Solid Tumors With Evidence of Activating RET Alteration;

    approved small molecule active

    1 trial

  47. SEMAGLUTIDE, SEMAGLUTIDE, INSULIN GLARGINE, DAPAGLIFLOZIN

    Fondazione Telethon ETS

    type 2 diabetes

    approved small molecule active

    1 trial

  48. SGLT2 inhibitor

    The First People's Hospital of Lianyungang

    Type2 Diabetes

    approved small molecule active

    1 trial

Frequently asked questions

How many Approved programs pipeline programs are in the directory?

1,839 published programs match this development stage in our ClinicalTrials.gov index.

What defines this pipeline stage?

Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.

Data attribution: Data sources · All pipeline programs

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.